ANIS AHMED KHAN
Salutation
Dr
School/Centre
School of Medicine
Department
Internal Medicine
Position
Senior Lecturer
Education
a
Certification Essentials of Imaging Science and Technology (Essentials of Imaging Science and Technology), 2022
Medical and Educational Academy Cardiff UK
a
PGHPE -Post Graduate Certificate Health Professional Education (Health Professional Education), 2019
International Medical University Malaysia
a
Certification License for Hemodialysis (Dialysis in Nephrology), 2018
MSM And MOH
a
Post Graduate Diploma Teaching (Education), 2013
Open University Malaysia
a
MRCP-Membership (Internal Medicine), 2005
Royal College of Physicians Ireland
a
Fellow College of Physicians and Surgeons Pakistan (Internal Medicine), 2002
College of Physicians and Surgeons Pakistan
a
Member College of Physicians and Surgeons Pakistan (Family Medicine), 1991
College of Physicians and Surgeons Pakistan
a
MBBS (Graduate Medicine & Surgery), 1985
Karachi University
Memberships
a
College of Physician Malaysia
Fellowship life time
2023 - Present
a
Academy of Medicine Malaysia
Member
2019 - Present
a
Malaysian Society Of Nephrology
Associate Member
2019 - Present
Research Funding
a
Barriers towards Practice of Organ Donation in the General Population: A Systematic Review in Malaysia
IMU Internal Research Grant | 2024-06-27 - 01 Mar 2025
a
Knowledge, attitude and practices of dengue patient admitted to Hospital Tuanku Ja’afar, Seremban, Malaysia
IMU Internal Research Grant | 2022-09-08 - 02 Feb 2024
Publications
Research Articles
a
Amit Garg A Mechanism Based Population Pharmacokinetic-Pharmacodynamic Model for Epoetin Alfa and Darbepoetin Alfa in Chronic Kidney Disease Patients
POSTER ABSTRACTS PAGE 2010 2025
a
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis
CLINICAL PHARMACOKINETICS 2024
a
1249P Older patients experience similar toxicity and survival outcomes to FLOT chemotherapy compared to younger patients
ANNALS OF ONCOLOGY 2022
a
Single-dose nirsevimab for prevention of RSV in preterm infants
NEW ENGLAND JOURNAL OF MEDICINE 2020
a
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
JOURNAL OF CLINICAL ONCOLOGY 2018
a
Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants
THE PEDIATRIC INFECTIOUS DISEASE JOURNAL 2018
a
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
SCIENCE TRANSLATIONAL MEDICINE 2017
a
Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2017
a
PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia Inpatients
VALUE IN HEALTH 2012
a
Serology based disease status of Pakistani population infected with Hepatitis B virus
BMC INFECTIOUS DISEASES 2007
a
Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse
MOLECULAR PHARMACEUTICS 2006
a
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
JOURNAL OF CLINICAL ONCOLOGY 2006
a
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2002
a
Antimalarial, antiviral, and antitoxoplasmosis norsesterterpene peroxide acids from the Red Sea sponge Diacarnus erythraeanus
JOURNAL OF NATURAL PRODUCTS 2001
a
Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation
CANCER CHEMOTHERAPY AND PHARMACOLOGY 1996
a
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
JOURNAL OF CLINICAL ONCOLOGY 1995
a
Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid
JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY 1993
a
Groundwater toxicity reduction evaluation
14 TH ANNUAL MEETING(SETAC)- ECOLOGICAL RISK ASSESSMENT: LESSONS LEARNED?-- ABSTRACT BOOK. VP. 1993. 1993
a
Phase I trial of 13-cis-retinoic acid (cis-RA) in neuroblastoma patients following bone marrow transplantation (BMT)
PROC. AM. SOC. CLIN. ONCOL 1992
a
The treatability approach to toxicity reduction evaluations: a case study
13 TH ANNUAL MEETING SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY- ABSTRACTS. VP. 1992. 1992
Other Publications
a
An electronic reminder as part of an educational intervention improves compliance with postoperative nausea and vomiting prophylaxis guidelines in ambulatory surgery patients.
ANAESTHESIA | 01 Jan 2013